Trials / Sponsors / Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc.
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusi Triple Negative Locally Advanced Non-resectable Breast Cancer, HR+, HER2-, Advanced Breast Cancer | Phase 1 / Phase 2 | 2025-03-24 |
| Recruiting | A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Part Advanced Solid Tumors, Genital Neoplasm, Female, Urogenital Neoplasms | Phase 1 / Phase 2 | 2023-01-04 |